Breakthroughs and Challenges: Psoriasis and treatment evolution
It is estimated that the worldwide prevalence of psoriasis
is 3% of the population. It can affect anyone regardless of race, age, and
geographical location. While genetic factors can contribute to the occurrence,
many who do not have a family history of psoriasis can also be affected.
Presentation can be mild to severe and can appear in different forms, ranging
from pustular to joint involvement. During the ZPT Expo held on September 23,
2022, we were privileged to be able to witness a discussion on a breakthrough
treatment for psoriasis – TALTZ® (Ixekizumab).
